Clinical and Genomic Characteristics of Patients With HR+/HER2− Metastatic Breast Cancer After Progression on a CDK4/6 Inhibitor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical and Genomic Characteristics of Patients with HR+, HER2- Metastatic Breast Cancer Following Progression on a CDK4 and 6 Inhibitor
Clin. Cancer Res 2023 Jun 08;[EPub Ahead of Print], X Rao, Y Chen, J Beyrer, E Nash Smyth, C Morato Guimaraes, LM Litchfield, L Bowman, GW Lawrence, A Aggarwal, F AndreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.